VEA
MDGL icon

Virtus ETF Advisers’s Madrigal Pharmaceuticals MDGL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,156
Closed -$357K 502
2024
Q4
$357K Sell
1,156
-33
-3% -$10.2K 0.15% 195
2024
Q3
$252K Hold
1,189
0.12% 240
2024
Q2
$333K Buy
1,189
+821
+223% +$230K 0.16% 208
2024
Q1
$98.3K Sell
368
-29
-7% -$7.74K 0.05% 367
2023
Q4
$91.9K Buy
397
+9
+2% +$2.08K 0.06% 398
2023
Q3
$56.7K Sell
388
-36
-8% -$5.26K 0.03% 409
2023
Q2
$97.9K Sell
424
-1,309
-76% -$302K 0.06% 396
2023
Q1
$420K Sell
1,733
-666
-28% -$161K 0.23% 143
2022
Q4
$696K Buy
2,399
+880
+58% +$255K 0.36% 118
2022
Q3
$99K Buy
1,519
+15
+1% +$978 0.04% 421
2022
Q2
$108K Sell
1,504
-635
-30% -$45.6K 0.04% 415
2022
Q1
$210K Sell
2,139
-131
-6% -$12.9K 0.09% 194
2021
Q4
$192K Buy
2,270
+294
+15% +$24.9K 0.07% 224
2021
Q3
$158K Sell
1,976
-102
-5% -$8.16K 0.07% 329
2021
Q2
$202K Sell
2,078
-402
-16% -$39.1K 0.08% 339
2021
Q1
$290K Buy
2,480
+36
+1% +$4.21K 0.12% 246
2020
Q4
$272K Sell
2,444
-435
-15% -$48.4K 0.11% 268
2020
Q3
$342K Sell
2,879
-408
-12% -$48.5K 0.18% 191
2020
Q2
$372K Sell
3,287
-396
-11% -$44.8K 0.18% 228
2020
Q1
$246K Sell
3,683
-543
-13% -$36.3K 0.1% 255
2019
Q4
$385K Buy
4,226
+1,626
+63% +$148K 0.06% 272
2019
Q3
$224K Sell
2,600
-144
-5% -$12.4K 0.05% 228
2019
Q2
$288K Buy
+2,744
New +$288K 0.06% 234
2019
Q1
Sell
-2,700
Closed -$304K 211
2018
Q4
$304K Buy
2,700
+1,122
+71% +$126K 0.05% 109
2018
Q3
$338K Sell
1,578
-1,121
-42% -$240K 0.03% 179
2018
Q2
$755K Sell
2,699
-6,930
-72% -$1.94M 0.67% 66
2018
Q1
$1.13M Buy
9,629
+5,247
+120% +$613K 0.98% 23
2017
Q4
$402K Buy
+4,382
New +$402K 0.5% 52